NEW YORK, August 18, 2026, 14:30 EDT – The Vanguard S&P 500 ETF (VOO) slipped 0.6% in trading, with five technology stocks responsible for 78% of the loss; UnitedHealth’s movements had no significant effect.
- VOO declined roughly 0.6%, and UnitedHealth remained mostly unchanged.
- About 78% of the ETF’s drop was driven by five technology stocks.
- UnitedHealth had a 0.51% weighting in the index, rendering its impact minimal.
The Vanguard S&P 500 ETF NYSEARCA:VOO slipped roughly 0.6% on Tuesday afternoon, while UnitedHealth Group Incorporated NYSE:UNH was little changed. This performance challenges a widespread suggestion that UnitedHealth was responsible for VOO’s decrease.
The difference is important for investors looking at automated market summaries. Knowing just a stock’s return does not show how it affects an index fund; the stock’s portfolio weight is just as significant.
UnitedHealth accounted for roughly 0.51% of the S&P 500 index. A fall of about 0.03% reduced the index by under 0.001 percentage point. The overall impact was negligible.
| ETF | Intraday price | Move | What it shows |
|---|---|---|---|
| Vanguard S&P 500 ETF NYSEARCA:VOO | $705.75 | -0.64% | Overall index slide |
| SPDR S&P 500 ETF Trust NYSEARCA:SPY | $767.90 | -0.62% | Move closely tracking the benchmark |
| iShares Core S&P 500 ETF NYSEARCA:IVV | $771.72 | -0.59% | Move closely tracking the benchmark |
The tight correlation among the three S&P 500 funds suggests a shift at the index level. It does not single out any specific health insurer as responsible.
Technology shares posted the biggest decline, with NVIDIA Corporation NASDAQ:NVDA, Micron Technology, Inc. NASDAQ:MU, Broadcom Inc. NASDAQ:AVGO, Meta Platforms, Inc. NASDAQ:META and Intel Corporation NASDAQ:INTC collectively reducing the index by around 0.50 percentage point.
| Holding | S&P 500 weight | Intraday return | Estimated index contribution |
|---|---|---|---|
| NVIDIA | 7.61% | -2.28% | -0.174 ppt |
| Micron Technology | 1.51% | -7.71% | -0.116 ppt |
| Broadcom | 2.59% | -3.14% | -0.081 ppt |
| Meta Platforms | 1.99% | -3.80% | -0.076 ppt |
| Intel | 0.72% | -7.31% | -0.053 ppt |
| Combined five-stock total | 14.42% | — | -0.499 ppt |
| UnitedHealth | 0.51% | -0.03% | -0.0002 ppt |
The investor perspective focuses on concentration. A group of five stocks, representing 14.42% of the index, were responsible for the bulk of the loss. UnitedHealth contributed roughly 0.02% to the drop.
VOO continues to provide notably low-cost access to the S&P 500. Vanguard states the expense ratio is 0.03%, with fund assets standing at $979 billion. The most recent fund report showed a bid-ask spread of 0.01%.
| VOO measure | Latest published value | As of |
|---|---|---|
| Expense ratio | 0.03% | April 28, 2026 |
| Total net assets | $979 billion | Latest Vanguard profile |
| One-year NAV return | 22.28% | June 30, 2026 |
| Dividend yield | 1.07% | June 30, 2026 |
UnitedHealth continues to be significant based on its core metrics. Revenue for the second quarter totaled $112.0 billion. Adjusted earnings per share came in at $6.38, and the medical care ratio stood at 86.7%. The group projected 2026 adjusted earnings between $19.50 and $20.00 per share.
Chief Executive Stephen Hemsley stated the results demonstrated advancement in streamlining operations. Barclays analyst Andrew Mok noted the quarter surpassed heightened investor expectations and brought forward the pace of recovery.
| UnitedHealth metric | Confirmed figure |
|---|---|
| Stock price | $395.20 |
| Total market value | $354.75 billion |
| P/E ratio | 25.41 |
| Q2 2026 sales | $112.0 billion |
| Q2 adjusted earnings per share | $6.38 |
| 2026 adjusted EPS outlook | $19.50-$20.00 |
Analysts largely stayed positive. According to Google Finance, there were 16 buy ratings and four holds, with zero sell recommendations. The average price target of $481.67 suggested an upside of roughly 22%.
| Analyst | Firm | Rating | Price target | Implied move |
|---|---|---|---|---|
| Erin Wright | Morgan Stanley | Buy | $529 | +33.9% |
| Lisa Gill | JPMorgan | Buy | $516 | +30.6% |
| Lance Wilkes | Bernstein | Buy | $512 | +29.6% |
| Sidharth Sahoo | HSBC | Hold | $380 | -3.8% |
| 20-analyst consensus | — | 16 Buy / 4 Hold | $481.67 | +21.9% |
Risks: Intraday prices and index weights are in constant flux. The displayed contribution values are initial estimates and do not represent final closing attribution. A rally or decline later in the session may change the order.
For VOO investors, the key takeaway is concentration, not a decline in healthcare. UnitedHealth is significant to the portfolio, but on Tuesday, its impact was limited.
Related articles: NASDAQ:META
